130 related articles for article (PubMed ID: 26525221)
1. Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial.
Barroso J; Bengtson AM; Gaynes BN; McGuinness T; Quinlivan EB; Ogle M; Heine A; Thielman NM; Pence BW
AIDS Behav; 2016 Feb; 20(2):235-42. PubMed ID: 26525221
[TBL] [Abstract][Full Text] [Related]
2. The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial.
Pence BW; Gaynes BN; Adams JL; Thielman NM; Heine AD; Mugavero MJ; McGuinness T; Raper JL; Willig JH; Shirey KG; Ogle M; Turner EL; Quinlivan EB
AIDS; 2015 Sep; 29(15):1975-86. PubMed ID: 26134881
[TBL] [Abstract][Full Text] [Related]
3. Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study.
Pence BW; Gaynes BN; Williams Q; Modi R; Adams J; Quinlivan EB; Heine A; Thielman N; Mugavero MJ
Contemp Clin Trials; 2012 Jul; 33(4):828-38. PubMed ID: 22542960
[TBL] [Abstract][Full Text] [Related]
4. Correlates of residual fatigue in patients with major depressive disorder: The role of psychotropic medication.
Chung KF; Yu YM; Yeung WF
J Affect Disord; 2015 Nov; 186():192-7. PubMed ID: 26247911
[TBL] [Abstract][Full Text] [Related]
5. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
6. Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics.
Sowa NA; Bengtson A; Gaynes BN; Pence BW
J Affect Disord; 2016 Mar; 192():153-61. PubMed ID: 26724694
[TBL] [Abstract][Full Text] [Related]
7. Somatic symptoms and HIV infection: relationship to depressive symptoms and indicators of HIV disease.
Perkins DO; Leserman J; Stern RA; Baum SF; Liao D; Golden RN; Evans DL
Am J Psychiatry; 1995 Dec; 152(12):1776-81. PubMed ID: 8526245
[TBL] [Abstract][Full Text] [Related]
8. Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning.
Millikin CP; Rourke SB; Halman MH; Power C
J Clin Exp Neuropsychol; 2003 Apr; 25(2):201-15. PubMed ID: 12754678
[TBL] [Abstract][Full Text] [Related]
9. Depression at Treatment Initiation Predicts HIV Antiretroviral Adherence in Uganda.
Wagner GJ; Slaughter M; Ghosh-Dastidar B
J Int Assoc Provid AIDS Care; 2017; 16(1):91-97. PubMed ID: 28084190
[TBL] [Abstract][Full Text] [Related]
10. Association of quality of life with major depressive disorder among people with HIV in South India.
Selvaraj V; Ross MW; Unnikrishnan B; Hegde S
AIDS Care; 2013; 25(2):169-72. PubMed ID: 22639937
[TBL] [Abstract][Full Text] [Related]
11. HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder.
Bech P; Boyer P; Germain JM; Padmanabhan K; Haudiquet V; Pitrosky B; Tourian KA
Pharmacopsychiatry; 2010 Nov; 43(7):271-6. PubMed ID: 20830664
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
13. Effect of Omega-3 Fatty Acids on Depressive Symptoms in HIV-Positive Individuals: A Randomized, Placebo-Controlled Clinical Trial.
Ravi S; Khalili H; Abbasian L; Arbabi M; Ghaeli P
Ann Pharmacother; 2016 Oct; 50(10):797-807. PubMed ID: 27323793
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.
Bingham KS; Whyte EM; Meyers BS; Mulsant BH; Rothschild AJ; Banerjee S; Flint AJ;
Am J Geriatr Psychiatry; 2015 Dec; 23(12):1270-1275. PubMed ID: 26560512
[TBL] [Abstract][Full Text] [Related]
15. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
17. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
18. Depressive symptoms and neurocognitive performance among HIV-infected women.
Fialho RM; Pereira M; Mendonça N; Ouakinin S
Women Health; 2013; 53(2):117-34. PubMed ID: 23517511
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential.
Gaynes BN; O'Donnell J; Nelson E; Heine A; Zinski A; Edwards M; McGuinness T; Riddhi MA; Montgomery C; Pence BW
Gen Hosp Psychiatry; 2015; 37(4):277-82. PubMed ID: 25892152
[TBL] [Abstract][Full Text] [Related]
20. Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon.
Gaynes BN; Pence BW; Atashili J; O'Donnell JK; Njamnshi AK; Tabenyang ME; Arrey CK; Whetten R; Whetten K; Ndumbe P
PLoS One; 2015; 10(10):e0140001. PubMed ID: 26469186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
